Journal of Medicinal Chemistry p. 6074 - 6086 (2006)
Update date:2022-07-30
Topics:
Venkatraman, Srikanth
Bogen, Stéphane L.
Arasappan, Ashok
Bennett, Frank
Chen, Kevin
Jao, Edwin
Liu, Yi-Tsung
Lovey, Raymond
Hendrata, Siska
Huang, Yuhua
Pan, Weidong
Parekh, Tejal
Pinto, Patrick
Popov, Veljko
Pike, Russel
Ruan, Sumei
Santhanam, Bama
Vibulbhan, Bancha
Wu, Wanli
Yang, Weiying
Kong, Jianshe
Liang, Xiang
Wong, Jesse
Liu, Rong
Butkiewicz, Nancy
Chase, Robert
Hart, Andrea
Agrawal, Sony
Ingravallo, Paul
Pichardo, John
Kong, Rong
Baroudy, Bahige
Malcolm, Bruce
Guo, Zhuyan
Prongay, Andrew
Madison, Vincent
Broske, Lisa
Cui, Xiaoming
Cheng, Kuo-Chi
Hsieh, Yunsheng
Brisson, Jean-Marc
Prelusky, Danial
Korfmacher, Walter
White, Ronald
Bogdanowich-Knipp, Susan
Pavlovsky, Anastasia
Bradley, Prudence
Saksena, Anil K.
Ganguly, Ashit
Piwinski, John
Girijavallabhan, Viyyoor
Njoroge, F. George
Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, which affects more than 170 million people worldwide. Currently the only therapeutic regimens are subcutaneous interferon-α or polyethylene glycol (PEG)-interferon-α alone or in combination with oral ribavirin. Although combination therapy is reasonably successful with the majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virological response. Herein, the SAR leading to the discovery of 70 (SCH 503034), a novel, potent, selective, orally bioavailable NS3 protease inhibitor that has been advanced to clinical trials in human beings for the treatment of hepatitis C viral infections is described. X-ray structure of inhibitor 70 complexed with the NS3 protease and biological data are also discussed.
View MoreShandong Ailitong New Material Co.,Ltd
Contact:+86-536-3226266
Address:zhongjia village, putong town , qingzhou city,Shandong Province,China
Suzhou Sibian Chemical Technology Co., Ltd
website:http://www.sibianpharm.com
Contact:+8618169181984,+8618013186906
Address:Room1404,BuildingA,Jiabao Square No.323 Baodai East Road,Wuzhong District,Suzhou Jiangsu China (215128)
Contact:+86-0760-85282375
Address:zhongjing road,zhongshan torch hi-tech industrial development zone
Jiangyin Tenghua Import&Export Co.,Ltd.
Contact:+86-510-86263875
Address:Room 402-B,9 Yanling Road, Jiangyin,Jiangsu, China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Doi:10.1021/jacs.8b05744
(2018)Doi:10.1055/s-1987-28174
(1987)Doi:10.1016/S0040-4039(00)96499-2
(1987)Doi:10.1002/jhet.38
(2009)Doi:10.1002/chem.200802483
(2009)Doi:10.1039/b820565e
(2009)